Silverarc Capital Management, LLC Wave Life Sciences Ltd. Transaction History
Silverarc Capital Management, LLC
- $402 Million
- Q3 2024
A detailed history of Silverarc Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 627,552 shares of WVE stock, worth $8.1 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
627,552
Previous 495,471
26.66%
Holding current value
$8.1 Million
Previous $2.47 Million
108.13%
% of portfolio
1.28%
Previous 0.7%
Shares
6 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$235 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$130 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$125 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$86.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$79.5 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.12B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...